Potential health and economic impact of paediatric vaccination using next‑generation influenza vaccines in Kenya: a modelling study

Influenza is a major year-round cause of respiratory illness in Kenya, particularly in children under 5.
Current influenza vaccines result in short-term, strain-specific immunity and were found in a previous study not to be cost-effective in Kenya. However, next-generation vaccines are in development that may have a greater impact and cost-effectiveness profile. Read full article here.